We have seen an uptick in reactions to Emend, with two in April (1.5% of cases) and four in June (7.7% of cases). Reactions included chest tightness, facial flushing, and itching.

Has anyone else noticed an increased incidence of Emend reactions?

NDC: 72205-083-01
Lot: CSE09034A
Exp: 8/31/27

NDC: 72205-083-01
Lot: CSE10035A
Exp: 9/30/27

Hello,

Our institution has been observing a recent increase in hypersensitivity reactions associated with fosaprepitant. The hypersensitivity reactions have been occurring within a minutes of infusion initiation, and has occurred with patients who have previously tolerated the infusion.

Has anyone observed any similar trends at their institutions?

Thank you,

Matthew Beaulac